Clinical Principles and Applications of Chemoirradiation

  • Dan P. Garwood
  • L. Chinsoo Cho
  • Hak Choy
Part of the Medical Radiology book series (MEDRAD)

3.9 Conclusion

The preceding discussion has been a brief overview of the varied ways in which chemotherapy and radiotherapy can be combined in treating patients with cancer. The practice of chemoirradiation is truly multidisciplinary and, as knowledge in the field expands, should play an increasing role in the control of neoplasms. As molecular biology brings us new targeted therapies, it is hoped that existing treatment regimens can be improved, in terms of both survival and ameliorating acute and late toxicity of therapy.


Rectal Cancer Clin Oncol Radiat Oncol Biol Phys Radiation Therapy Oncology Group Concurrent Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Al Sarraf M, Martz K, Herskovic A et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277–284Google Scholar
  2. Al-Sarraf M, LeBlanc M, Giri PG et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol 16:1310–1317PubMedGoogle Scholar
  3. Anonymous (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685–1690CrossRefGoogle Scholar
  4. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484PubMedCrossRefGoogle Scholar
  5. Bagshaw MA (1961) Possible role of potentiators in radiation therapy. Am J Roentgenol 85:822–833Google Scholar
  6. Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040–2049PubMedGoogle Scholar
  7. Baselga J, Pfister D, Cooper MR et al (2000) Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol 18:904–914PubMedGoogle Scholar
  8. Begg AC, van der Kolk PJ, Emondt J et al (1987) Radiosensitization in vitro by cis-diammine (1,1-cyclobutanedicarboxylato) platinum(II) (carboplatin, JM8) and ethylenediammine-malonatoplatinum(II) (JM40). Radiother Oncol 9:157–165PubMedGoogle Scholar
  9. Bonnen M, Crane C, Vauthey JN et al (2004) Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60:1098–1105PubMedCrossRefGoogle Scholar
  10. Bonner J, Harari P, Giralt N et al (2004) Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck: a phase III study of high dose radiation therapy with or without cetuximab. J Clin Oncol Annu Meeting Proc Abstract no. 5507Google Scholar
  11. Bosset JF, Gignoux M, Triboulet JP et al (1997) Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161–167PubMedCrossRefGoogle Scholar
  12. Bosset JF, Roelofsen F, Morgan DA, Budach V, Coucke P, Jager JJ, Van der Steen-Banasik E, Triviere N, Stuben G, Puyraveau M, Mercier M; European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups (2003) Shortened irradiation scheme, continuous infusion of 5-fluorouracil and fractionation of mitomycin C in locally advanced anal carcinomas. Results of a phase II study of the European Organization for Research and Treatment of Cancer. Radiotherapy and Gastrointestinal Cooperative Groups. Eur J Cancer 39:45–51PubMedCrossRefGoogle Scholar
  13. Bosset JF, Calais G, Daban, A et al (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40:219–224PubMedCrossRefGoogle Scholar
  14. Bourhis J, Pignon JP (1999) Meta-analyses in head and neck squamous cell carcinoma. What is the role of chemotherapy? Hematol Oncol Clin North Am 13:769–775, viiPubMedCrossRefGoogle Scholar
  15. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B (2005) Toxicity and outcome results of RTOG 9311: a phase I–II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61:318–328PubMedCrossRefGoogle Scholar
  16. Bristow RG, Hill RP (1998) Molecular and cellular basis of radiotherapy. In: Tannock IF, Hill RP (eds) The basic science of oncology, 3rd edn. McGraw-Hill, Montreal, pp 295–321Google Scholar
  17. Buchholz DJ, Lepek KJ, Rich TA et al (1995) 5-Fluorouracilradiation interactions in human colon adenocarcinoma cells. Int J Radiat Oncol Biol Phys 32:1053–1058PubMedCrossRefGoogle Scholar
  18. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy versus conventionally fractionated radiochemotherapy. Radiother Oncol 72:15–24PubMedCrossRefGoogle Scholar
  19. Cafiero F, Gipponi M, Lionetto R et al (2003) Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levemisole in patients with stage II-III respectable rectal cancer: a final report. J Surg Oncol 83:140–146PubMedCrossRefGoogle Scholar
  20. Cakir S, Egehan I (2004) A randomised clinical trial of radiotherapy plus cisplatin versus radiotherapy alone in stage III non-small cell lung cancer. Lung Cancer 43:309–316PubMedCrossRefGoogle Scholar
  21. Choy H, Akerley W, Safran H et al (1998a) Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 16:3316–3322PubMedGoogle Scholar
  22. Choy H, Safran H, Akerley W et al (1998b) Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clin Cancer Res 4:1931–1936PubMedGoogle Scholar
  23. Choy H et al (1993) Investigation of taxol as potential radiation sensitizer. Cancer 71:3774–3778PubMedCrossRefGoogle Scholar
  24. Coppin CML, Gospodarowicz M, James K et al (1996) Improved local control of invasive bladder cancer by concurrent cis-platin and preoperative or definitive radiation. J Clin Oncol 14:2901–2907PubMedGoogle Scholar
  25. Crane CH, Skibber JM, Birnbaum EH et al (2003) The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advances rectal cancer. Int J Radiat Oncol Biol Phys 57:84–89PubMedCrossRefGoogle Scholar
  26. Cummings BJ, Keane TJ, O’Sullivan B et al (1991) Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 21:115–125Google Scholar
  27. Curran W, Scott C, Langer C et al (2000) Phase III comparison of sequential vs concurrent chemo-radiation for pts with unresected stage III non-small cell lung cancer (NSCLC): report of Radiation Therapy Oncology Group (RTOG) 9410 (abstract 303). Lung Cancer 29[Suppl 1]:93CrossRefGoogle Scholar
  28. Dautzenberg B, Arriagada R, Chammard AB et al (1999) A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d’Etude et de Traitement des Cancers Bronchiques. Cancer 86:265–273PubMedCrossRefGoogle Scholar
  29. Dewit L (1987) Combined treatment of radiation and cis-diamminedichloroplatinum (II): a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13:403–426PubMedGoogle Scholar
  30. Dillman RO, Herndon J, Seagren SL et al (1996) Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 88:1210–1215PubMedGoogle Scholar
  31. Dunst J, Sauer R, Schrott KM et al (1994) An organ sparing treatment of advanced bladder carcinoma: a 10-year experience. Int J Radiat Oncol Biol Phys 30:261–266PubMedGoogle Scholar
  32. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22:872–880PubMedCrossRefGoogle Scholar
  33. Elkind MM, Sutton HF (1959) X-ray damage and recovery in mammalian cells in culture. Nature 184:1293PubMedGoogle Scholar
  34. El-Sayed S, Nelson N (1996) Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region. A meta-analysis of prospective and randomized trials. J Clin Oncol 14:838–847PubMedGoogle Scholar
  35. Fisher B, Wolmark N, Rockette H et al (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80:21–29PubMedGoogle Scholar
  36. Flam M, John M, Pajak TF et al (1996) Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoidcarcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14:2527–2539PubMedGoogle Scholar
  37. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098PubMedCrossRefGoogle Scholar
  38. Freyer G, Bossard N, Romestaing P et al (2001) Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial. J Clin Oncol 19:2433–2438PubMedGoogle Scholar
  39. Fried DB, Morris DE, Poole C et al (2004) A metaanalysis of the timing of chest irradiation in combined modality treatment of limited-stage small cell lung cancer. J Clin Oncol 22:4837–4845PubMedCrossRefGoogle Scholar
  40. Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16PubMedCrossRefGoogle Scholar
  41. Furuse K, Fukuoka M, Kawahara M et al (1999) Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17:2692–2699PubMedGoogle Scholar
  42. Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472CrossRefGoogle Scholar
  43. Gastrointestinal Tumor Study Group (1992) Radiation therapy and fluorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10:549–557Google Scholar
  44. George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N (2004) Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 64:488–493PubMedCrossRefGoogle Scholar
  45. Gilman A (1963) The initial clinical trial of nitrogen mustard. Am J Surg 105:574–578PubMedCrossRefGoogle Scholar
  46. Glaser C, Millesi W, Kornek G et al (2001) Impact of hemoglobin level and the use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx. Int J Radiat Oncol Biol Phys 50:705–715PubMedCrossRefGoogle Scholar
  47. Gregoire V, Hittelman WN, Rosier JF, Milas L (1999) Chemoradiotherapy: radiosensitizing nucleoside analogues. Oncol Rep 6:949–957PubMedGoogle Scholar
  48. Hall EJ (1994) Radiobiology for the radiobiologist, 4th edn. Lippincott, PhiladelphiaGoogle Scholar
  49. Heidelberger C, Chaudhari N, Dannenberg P et al (1957) Fluorinated pyrimidines: new class of tumor-inhibiting compounds. Nature 179:663PubMedCrossRefGoogle Scholar
  50. Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, Chu K, McEwan AJ, Halperin R, Roa WH (2004) Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 73:285–287PubMedCrossRefGoogle Scholar
  51. Horiot JC, Le Fur R, N’Guyen T et al (1992) Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231–241PubMedCrossRefGoogle Scholar
  52. Housset M, Maulard C, Chretien YC et al (1993) Combined radiation and chemotherapy for invasive transitional cell carcinoma of the bladder: a prospective study. J Clin Oncol 11:2150–2157PubMedGoogle Scholar
  53. Hsiang YH, Liu LF (1988) Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48:1722–1726PubMedGoogle Scholar
  54. Hsiang YH, Hertzberg R, Hecht S et al (1985) Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 260:14873–14878PubMedGoogle Scholar
  55. Kaufman DS, Shipley WU, Griffin PP et al (1993) Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 329:1377–1382PubMedCrossRefGoogle Scholar
  56. Keller SM, Adak S, Wagner H et al (2000) A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 343:1217–1222PubMedCrossRefGoogle Scholar
  57. Keys HM, Bundy BN, Stehman FB et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340:1154–1161PubMedCrossRefGoogle Scholar
  58. Kinsella TJ, Dobson PP, Mitchell JB, Fornace AJ Jr. (1987) Enhancement of X ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. Int J Radiat Oncol Biol Phys 13:733–739PubMedGoogle Scholar
  59. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR Jr, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD (2004) Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58:1369–1377PubMedCrossRefGoogle Scholar
  60. Kotalik J, Yu E, Markman BR et al (2001) Practice guideline on prophylactic cranial irradiation in small-cell lung cancer. Int J Radiat Oncol Biol Phys 50:309–316PubMedCrossRefGoogle Scholar
  61. Kuczyk M, Turkeri L, Hammerer P, Ravery V, European Society for Oncological Urology (2003) Is there a role for bladder preserving strategies in the treatment of muscle-invasive bladder cancer? Eur Urol 44:57–64PubMedCrossRefGoogle Scholar
  62. Lawrence TS, Eisbruch A, Shewach DS (1997) Gemcitabine-mediated radiosensitization. Semin Oncol 24:S-7,24–S7,28Google Scholar
  63. Le Chevalier T, Arriagada R, Quoix E et al (1991) Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417–423PubMedGoogle Scholar
  64. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890–899PubMedGoogle Scholar
  65. Lehman M, Thomas G (2001) Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer? Int J Gynecol Cancer 11:87–99PubMedCrossRefGoogle Scholar
  66. Little JB, Hahn GM, Frindel E, Tubiana M (1973) Repair of potentially lethal radiation damage in vitro and in vivo. Radiology 106:689PubMedGoogle Scholar
  67. Lonardi S, Tosoni A, Brandes A (2005) Adjuvant chemotherapy in the treatment of high grade gliomas. Cancer Treat Rev 31:79–89PubMedCrossRefGoogle Scholar
  68. Mason KA, Komaki R, Cox JD, Milas L (2001) Biology-based combined-modality radiotherapy: workshop report. Int J Radiat Oncol Biol Phys 50:1079–1089PubMedCrossRefGoogle Scholar
  69. Mauceri HJ, Hanna NN, Beckett MA et al (1998) Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 394:287–291PubMedCrossRefGoogle Scholar
  70. Mehta VK, Cho C, Ford JM, Jambalos C, Poen J, Koong A, Lin A, Bastidas JA, Young H, Dunphy EP, Fisher G (2003) Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int J Radiat Oncol Biol Phys 55:132–137PubMedCrossRefGoogle Scholar
  71. Mendelsohn J, Fan Z (1997) Epidermal growth factor receptor family and chemosensitization. J Natl Cancer Inst 89:341–343PubMedCrossRefGoogle Scholar
  72. Milas L, Nakayama T, Hunter N et al (1994) Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide. Radiother Oncol 30:247–253PubMedCrossRefGoogle Scholar
  73. Milas L, Hunter NR, Mason KA et al (1995) Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res 55:3564–3568PubMedGoogle Scholar
  74. Milas L, Fujii T, Hunter N et al (1999a) Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res 59:107–114PubMedGoogle Scholar
  75. Milas L, Milas MM, Mason KA (1999b) Combination of taxanes with radiation: preclinical studies. Semin Radiat Oncol 9:12–26PubMedGoogle Scholar
  76. Minsky BD (2004a) Combined-modality therapy of rectal cancer with irinocetan-based regimens. Oncology (Huntingt) 18:49–55PubMedGoogle Scholar
  77. Minsky BD (2004b) Combined-modality therapy of rectal cancer with oxaliplatin-based regimens. Clin Colorectal Cancer 4[Suppl 1]:S29–S36PubMedCrossRefGoogle Scholar
  78. Minsky BD, Berkey B, Kelsen D et al (2000) Preliminary results of Intergroup INT 0123 Randomized Trial of Combined Modality Therapy (CMT) for esophageal cancer: standard vs. high dose radiation therapy. Proc Am Soc Clin Oncol 19:239aGoogle Scholar
  79. Morris M, Eifel PJ, Lu J et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143PubMedCrossRefGoogle Scholar
  80. Munro AJ (1995) An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 71:83–91PubMedGoogle Scholar
  81. Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356PubMedGoogle Scholar
  82. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450CrossRefGoogle Scholar
  83. O’Connell MJ, Martenson JA, Wieand HS et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507PubMedCrossRefGoogle Scholar
  84. O’Hara JA, Douple EB, Richmond RC (1986) Enhancement of radiation-induced cell kill by platinum complexes (carboplatin and iproplatin) in V79 cells. Int J Radiat Oncol Biol Phys 12:1419–1422PubMedGoogle Scholar
  85. Pearcey RG, Brundage MD, Drouin P et al (2000) A clinical trial comparing concurrent cisplatin and radiation therapy versus radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group. Proc Am Soc Clin Oncol 19:378aGoogle Scholar
  86. Penland SK, Socinski MA. (2004) Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation. Semin Radiat Oncol 14:326–334PubMedCrossRefGoogle Scholar
  87. Peters WA 3rd, Liu PY, Barrett RJ 2nd et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18:1606–1613PubMedGoogle Scholar
  88. Pignon JP, Arriagada R, Ihde DC et al (1992) A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327(23):1618–1624PubMedCrossRefGoogle Scholar
  89. Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955PubMedGoogle Scholar
  90. Plunkett W, Huang P, Xu YZ et al (1995) Gemcitabine: metabolism, mechanisms of action, and self-potentiation. Semin Oncol 22[4 Suppl 11]:3–10PubMedGoogle Scholar
  91. Pritchard RS, Anthony SP (1996) Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. Ann Intern Med 125:723–729PubMedGoogle Scholar
  92. Raben D, Helfrich B, Bunn PA Jr. (2004) Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective. Int J Radiat Oncol Biol Phys 59[2 Suppl]:27–38PubMedCrossRefGoogle Scholar
  93. Radford IR (1986) Evidence for a general relationship between the induced level of DNA double-strand breakage and cell-killing after X-irradiation of mammalian cells. Int J Radiat Biol 49:611–620Google Scholar
  94. Rose PG, Bundy BN, Watkins J et al (1999) Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153PubMedCrossRefGoogle Scholar
  95. Rowell NP, O’Rourke NP (2004) Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 18:CD002140Google Scholar
  96. Rowinsky EK (1997) The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 48:353–374PubMedCrossRefGoogle Scholar
  97. Sauer R, Fietkau R, Martus P et al (2000) Adjuvant and neoadjuvant radiochemotherapy or advanced rectal cancer — first results of the German multicenter phase-III-trial (abstract). Int J Radiat Oncol Biol Phys 48[3 Suppl]:119aCrossRefGoogle Scholar
  98. Sauer R, Fietkau C, Wittekind C et al (2004) Pre-operative versus post-operative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRefGoogle Scholar
  99. Sause W, Kolesar P, Taylor S et al (2000) Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 117:358–364PubMedCrossRefGoogle Scholar
  100. Scalliet P, Goor C, Galdermans D et al (1998) Gemzar (Gemcitabine) with thoracic radiotherapy — a phase II pilot study in chemonaive patients with advanced nonsmall cell lung cancer (NSCLC) (abstract). Proc Am Soc Clin Oncol 17:1923Google Scholar
  101. Schaake-Koning C, Van den Bogart W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 326:524–530PubMedCrossRefGoogle Scholar
  102. Schmidt-Ullrich RK, Dent P, Grant S et al (2000) Signal transduction and cellular radiation responses. Radiat Res 153:245–257PubMedCrossRefGoogle Scholar
  103. Shipley WU, Kaufman DS, Tester WJ, Pilepich MV, Sandler HM, Radiation Therapy Oncology Group (2003) Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Cancer 97[8 Suppl]:2115–2119PubMedCrossRefGoogle Scholar
  104. Smith TJ, Ryan LM, Douglass HO Jr. et al (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269–276PubMedCrossRefGoogle Scholar
  105. Steel GG, Peckham MJ (1979) Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5:85–91PubMedGoogle Scholar
  106. Stephens T, Steel GG (1980) Regeneration of tumors after cytotoxic treatment. In: Meyn R, Withers HR (eds) Radiation biology in cancer research. Raven, New York, pp 385–295Google Scholar
  107. Stupp R, Mason W, van den Bent M et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRefGoogle Scholar
  108. Teicher BA, Holden SA, Dupuis NP et al (1995) Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma. Breast Cancer Res Treat 36:227–236PubMedCrossRefGoogle Scholar
  109. Tepper JE, O’Connell MJ, Petroni GR et al (1997) Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 15:2030–2039PubMedGoogle Scholar
  110. Terasima T, Tolmach LJ (1963) Variations in survival responses of HeLa cells to X-irradiation during the division cycle. Biophysics J 3:11–33CrossRefGoogle Scholar
  111. Tester W, Porter A, Asbell S et al (1993) Combined modality program with possible organ preservation for invasive bladder carcinoma: results of the RTOG protocol 85–12. Int J Radiat Oncol Biol Phys 25:783–790PubMedGoogle Scholar
  112. Thomas GM (1999) Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 340:1198–1200PubMedCrossRefGoogle Scholar
  113. Tishler RB, Geard CR, Hall EJ, Schiff PB (1992) Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52:3495–3497PubMedGoogle Scholar
  114. Turrisi AT 3rd, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271PubMedCrossRefGoogle Scholar
  115. UKCCCR (1996) Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Coordinating Committee on Cancer Research. Lancet 348:1049–1054CrossRefGoogle Scholar
  116. Urba SG, Orringer MB, Turrisi A et al (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19:305–313PubMedGoogle Scholar
  117. Walsh TN, Noonan N, Hollywood D et al (1996) A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462–467PubMedCrossRefGoogle Scholar
  118. Wang Y, Pantelias GE, Iliakis G (1994) Mechanism of radiosensitization by halogenated pyrimidines: the contribution of excess DNA and chromosome damage in BrdU radiosensitization may be minimal in plateau-phase cells. Int J Radiat Biol 66:133–142PubMedGoogle Scholar
  119. Warde P, Payne D (1992) Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10:890–895PubMedGoogle Scholar
  120. Willett C, Boucher Y, di Tomaso et al (2004) Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med 10:145PubMedCrossRefGoogle Scholar
  121. Wolmark N, Wieand HS, Hyams DM et al (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388–396PubMedCrossRefGoogle Scholar
  122. Zhu AX, Willett CG (2005) Combined modality treatment for rectal cancer. Semin Oncol 32:103–112PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2006

Authors and Affiliations

  • Dan P. Garwood
    • 1
  • L. Chinsoo Cho
    • 1
  • Hak Choy
    • 1
  1. 1.Department of Radiation OncologyUT Southwestern Medical Center at DallasDallasUSA

Personalised recommendations